Een ogenblik geduld, de kaartgegevens worden geladen
AstraZeneca PLC-community
About AstraZeneca PLC
What is AstraZeneca PLC?
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is € 176,65, with a 24-hour trading volume of € 318,4M. The asset's market cap is € 273,95B, after moving 2.19% in the last day.
Tokenized AstraZeneca PLC is trading at € 89,26, with a tokenized market cap of € 669,47K and a 24-hour trading volume of € 551,37K. The tokenized asset has moved 0.38% in the past 24 hours.